BN.TO Quote, Financials, Valuation and Earnings

Sol Strategies has a net margin of 0.41% compared to Brookfield's net margin of -190.65%. Brookfield's return on equity of 0.37% beat Sol Strategies's return on equity of 5.13%.

Brookfield has a consensus price target of $72.72, signalling downside risk potential of -16.3%. On the other hand Sol Strategies has an analysts' consensus of $4.0000 which suggests that it could grow by 88.68%. Given that Sol Strategies has higher upside potential than Brookfield, analysts believe Sol Strategies is more attractive than Brookfield.

Brookfield has a beta of 2.063, which suggesting that the stock is 106.311% more volatile than S&P 500. In comparison Sol Strategies has a beta of 2.944, suggesting its more volatile than the S&P 500 by 194.411%.

Brookfield has a quarterly dividend of $0.12 per share corresponding to a yield of 0.53%. Sol Strategies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brookfield pays 103.43% of its earnings as a dividend. Sol Strategies pays out -- of its earnings as a dividend.

Brookfield quarterly revenues are $25.7B, which are larger than Sol Strategies quarterly revenues of $2.5M. Brookfield's net income of $104.6M is higher than Sol Strategies's net income of -$4.8M. Notably, Brookfield's price-to-earnings ratio is 230.25x while Sol Strategies's PE ratio is 212.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brookfield is 1.27x versus 18.75x for Sol Strategies. Usually stocks with elevated PS ratios are considered overvalued.

Global Wellness Strategies has a net margin of 0.41% compared to Brookfield's net margin of --. Brookfield's return on equity of 0.37% beat Global Wellness Strategies's return on equity of --.

Brookfield has a consensus price target of $72.72, signalling downside risk potential of -16.3%. On the other hand Global Wellness Strategies has an analysts' consensus of -- which suggests that it could fall by --. Given that Brookfield has higher upside potential than Global Wellness Strategies, analysts believe Brookfield is more attractive than Global Wellness Strategies.

Brookfield has a beta of 2.063, which suggesting that the stock is 106.311% more volatile than S&P 500. In comparison Global Wellness Strategies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Brookfield has a quarterly dividend of $0.12 per share corresponding to a yield of 0.53%. Global Wellness Strategies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brookfield pays 103.43% of its earnings as a dividend. Global Wellness Strategies pays out -- of its earnings as a dividend.

Brookfield quarterly revenues are $25.7B, which are larger than Global Wellness Strategies quarterly revenues of --. Brookfield's net income of $104.6M is higher than Global Wellness Strategies's net income of --. Notably, Brookfield's price-to-earnings ratio is 230.25x while Global Wellness Strategies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brookfield is 1.27x versus -- for Global Wellness Strategies. Usually stocks with elevated PS ratios are considered overvalued.

Quinsam Capital has a net margin of 0.41% compared to Brookfield's net margin of -234.02%. Brookfield's return on equity of 0.37% beat Quinsam Capital's return on equity of -29.43%.

Brookfield has a consensus price target of $72.72, signalling downside risk potential of -16.3%. On the other hand Quinsam Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that Brookfield has higher upside potential than Quinsam Capital, analysts believe Brookfield is more attractive than Quinsam Capital.

Brookfield has a beta of 2.063, which suggesting that the stock is 106.311% more volatile than S&P 500. In comparison Quinsam Capital has a beta of 0.857, suggesting its less volatile than the S&P 500 by 14.332%.

Brookfield has a quarterly dividend of $0.12 per share corresponding to a yield of 0.53%. Quinsam Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brookfield pays 103.43% of its earnings as a dividend. Quinsam Capital pays out -- of its earnings as a dividend.

Brookfield quarterly revenues are $25.7B, which are larger than Quinsam Capital quarterly revenues of $13.8K. Brookfield's net income of $104.6M is higher than Quinsam Capital's net income of $159.8K. Notably, Brookfield's price-to-earnings ratio is 230.25x while Quinsam Capital's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brookfield is 1.27x versus -- for Quinsam Capital. Usually stocks with elevated PS ratios are considered overvalued.

New Frontier Ventures has a net margin of 0.41% compared to Brookfield's net margin of --. Brookfield's return on equity of 0.37% beat New Frontier Ventures's return on equity of --.

Brookfield has a consensus price target of $72.72, signalling downside risk potential of -16.3%. On the other hand New Frontier Ventures has an analysts' consensus of -- which suggests that it could fall by --. Given that Brookfield has higher upside potential than New Frontier Ventures, analysts believe Brookfield is more attractive than New Frontier Ventures.

Brookfield has a beta of 2.063, which suggesting that the stock is 106.311% more volatile than S&P 500. In comparison New Frontier Ventures has a beta of -1.248, suggesting its less volatile than the S&P 500 by 224.781%.

Brookfield has a quarterly dividend of $0.12 per share corresponding to a yield of 0.53%. New Frontier Ventures offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brookfield pays 103.43% of its earnings as a dividend. New Frontier Ventures pays out -- of its earnings as a dividend.

Brookfield quarterly revenues are $25.7B, which are larger than New Frontier Ventures quarterly revenues of --. Brookfield's net income of $104.6M is higher than New Frontier Ventures's net income of -$9.5K. Notably, Brookfield's price-to-earnings ratio is 230.25x while New Frontier Ventures's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brookfield is 1.27x versus 29.93x for New Frontier Ventures. Usually stocks with elevated PS ratios are considered overvalued.